Leblond, P., Navarin, P., Arcicasa, M., Bal-Mahieu, C., Lemahieu, N., Völkel, P., . . . Meignan, S. (2016). PCM-13 THE HYPOXIA-ACTIVATED PRODRUG EVOFOSFAMIDE (TH-302) IS EFFICACIOUS IN PEDIATRIC HIGH GRADE GLIOMA CELL LINES AS A MONOTHERAPY AND IN COMBINATION WITH CHEMOTHERAPIES. Neuro Oncol.

Leblond, Pierre, Pauline Navarin, Mélanie Arcicasa, Christine Bal-Mahieu, Nicole Lemahieu, Pamela Völkel, Eric Lartigau, Pierre-Olivier Angrand, and Samuel Meignan. "PCM-13 THE HYPOXIA-ACTIVATED PRODRUG EVOFOSFAMIDE (TH-302) IS EFFICACIOUS IN PEDIATRIC HIGH GRADE GLIOMA CELL LINES AS A MONOTHERAPY AND IN COMBINATION WITH CHEMOTHERAPIES." Neuro Oncol 2016.

Leblond, Pierre, et al. "PCM-13 THE HYPOXIA-ACTIVATED PRODRUG EVOFOSFAMIDE (TH-302) IS EFFICACIOUS IN PEDIATRIC HIGH GRADE GLIOMA CELL LINES AS A MONOTHERAPY AND IN COMBINATION WITH CHEMOTHERAPIES." Neuro Oncol 2016.